{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-006201","form_type":"8-K","ticker":"BGMS","cik":"0001130166","company_name":"Bio Green Med Solution, Inc.","filed_at":"2025-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.605747+00:00","generated_at":"2026-05-23T05:40:38.190422+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Cyclacel increases authorized common shares from 250M to 600M; removes Series E conversion cap","bullets":["Board and majority stockholder approved Certificate of Amendment filed April 25, 2025.","Authorized common stock increased from 250,000,000 to 600,000,000 shares; no change to issued shares.","Amended Series E Certificate of Designation removes the 4.99% ownership limitation on conversion and voting.","Removal of Series E cap allows unlimited conversion of preferred into common shares going forward.","Both amendments effective upon filing with Delaware Secretary of State on April 25, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-006201","json":"https://secwatch.observer/filing/0001641172-25-006201.json","markdown":"https://secwatch.observer/filing/0001641172-25-006201.md","text":"https://secwatch.observer/filing/0001641172-25-006201.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130166/000164117225006201/0001641172-25-006201-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130166/000164117225006201/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T05:40:38.190422+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}